ImmunoPrecise Antibodies Ownership | Who Owns ImmunoPrecise Antibodies?


OverviewRevenueFinancialsChartTranscripts

ImmunoPrecise Antibodies Ownership Summary


ImmunoPrecise Antibodies is owned by 6.99% institutional investors, 12.06% insiders, and 80.95% retail investors. Ingalls & snyder is the largest institutional shareholder, holding 5.02% of IPA shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in ImmunoPrecise Antibodies shares.

IPA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmunoPrecise Antibodies6.99%12.06%80.95%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ingalls & snyder1.30M5.02%$1.31M
Renaissance63.91K0.25%$64.55K
Bank of montreal /can/55.86K0.22%$61.44K
Northern trust50.73K0.20%$51.24K
Cibc world market41.20K0.16%$42.00K
Federation des caisses desjardins du quebec27.03K0.10%$27.30K
Gradient capital advisors26.81K0.10%$27.08K
Geode capital management17.48K0.07%$17.66K
Rathbones group14.00K0.05%$14.14K
Xtx topco12.70K0.05%$12.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder1.30M0.06%$1.31M
Gradient capital advisors26.81K0.01%$27.08K
Xtx topco12.70K0.00%$12.82K
West paces advisors1.67K0.00%$1.68K
Cibc world market41.20K0.00%$42.00K
Renaissance63.91K0.00%$64.55K
Rathbones group14.00K0.00%$14.14K
Federation des caisses desjardins du quebec27.03K0.00%$27.30K
Two sigma securities---
Simplex trading7.65K-$7.00K

Top Buyers

HolderShares% AssetsChange
Renaissance63.91K0.00%26.31K
Xtx topco12.70K0.00%12.70K
Ubs group12.23K-9.75K
Ingalls & snyder1.30M0.06%6.91K
Simplex trading7.65K-6.64K

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp---32.99K
Two sigma securities---23.35K
Royal bank of canada---17.60K
Dimensional fund advisors lp---12.21K
Wolverine trading---11.00K

Sold Out

HolderChange
Tower research capital llc (trc)-3.00
Wolverine trading-11.00K
Dimensional fund advisors lp-12.21K
Royal bank of canada-17.60K
Two sigma securities-23.35K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202417-19.05%1,897,10614.54%616.97%6-14.29%3-
Jun 30, 202421-19.23%1,656,275-0.97%614.40%7-12.50%3-40.00%
Mar 31, 202426-3.70%1,672,577-4.24%613.73%8-38.46%525.00%
Dec 31, 20232722.73%1,746,59626.66%622.97%13160.00%4-50.00%
Sep 30, 20232215.79%1,378,939-7.05%515.57%525.00%833.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index17.48K0.06%-

IPA Ownership FAQ


Who Owns ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies shareholders are primarily institutional investors at 6.99%, followed by 12.06% insiders and 80.95% retail investors. The average institutional ownership in ImmunoPrecise Antibodies's industry, Biotech Stocks , is 47.04%, which ImmunoPrecise Antibodies falls below.

Who owns the most shares of ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies’s largest shareholders are Ingalls & snyder (1.3M shares, 5.02%), Renaissance (63.91K shares, 0.25%), and Bank of montreal /can/ (55.86K shares, 0.22%). Together, they hold 5.49% of ImmunoPrecise Antibodies’s total shares outstanding.

Does Blackrock own ImmunoPrecise Antibodies?

BlackRock is not among the top 10 institutional shareholders of ImmunoPrecise Antibodies.

Who is ImmunoPrecise Antibodies’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is ImmunoPrecise Antibodies’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 1.3M ImmunoPrecise Antibodies shares, valued at 1.31M$.

Who is the top mutual fund holder of ImmunoPrecise Antibodies shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of ImmunoPrecise Antibodies shares, with 0.06% of its total shares outstanding invested in 17.48K ImmunoPrecise Antibodies shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools